Atika Capital Management LLC Trims Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atika Capital Management LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 53,600 shares of the medical equipment provider’s stock after selling 600 shares during the period. Intuitive Surgical accounts for 3.0% of Atika Capital Management LLC’s portfolio, making the stock its 6th largest holding. Atika Capital Management LLC’s holdings in Intuitive Surgical were worth $27,977,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the fourth quarter worth $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical in the fourth quarter worth $28,000. Hurley Capital LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at $28,000. Finally, Summit Securities Group LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 in the last three months. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 8.7 %

ISRG opened at $451.58 on Friday. The company has a market capitalization of $160.84 billion, a price-to-earnings ratio of 70.45, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The business’s fifty day simple moving average is $545.18 and its 200-day simple moving average is $532.64.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent research reports. Bernstein Bank upped their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Truist Financial lowered their price objective on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a research note on Monday, March 17th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Erste Group Bank lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.